| Bioactivity | AB-506 is an orally active inhibitor of HBV replication targeting the viral core protein. AB-506 can bind to HBV core protein, accelerate capsid assembly and inhibit HBV pgRNA encapsidation. AB-506 can be used in chronic hepatitis B (CHB) research[1]. |
| Name | AB-506 |
| CAS | 2245020-50-0 |
| Formula | C21H18ClF2N5O3 |
| Molar Mass | 461.85 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Nagraj Mani, et al. Preclinical characterization of AB-506, an inhibitor of HBV replication targeting the viral core protein. Antiviral Res. 2022 Jan;197:105211. |
AB-506
CAS: 2245020-50-0 F: C21H18ClF2N5O3 W: 461.85
AB-506 is an orally active inhibitor of HBV replication targeting the viral core protein. AB-506 can bind to HBV core pr
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.